---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-25-269654"
form_type: "8-K"
ticker: "ORGO"
cik: "0001661181"
company_name: "Organogenesis Holdings Inc."
filed_at: "2025-11-06T23:59:59+00:00"
generated_at: "2026-05-16T23:45:41.726718+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Organogenesis posts record Q3 revenue of $150.5M, raises FY2025 guidance

## Summary
- Net product revenue $150.5M (+31% YoY); Advanced Wound Care $141.5M (+31%), Surgical & Sports Med $9.0M (+25%).
- Net income $21.6M ($0.11 diluted EPS) vs $12.3M ($0.09) YoY; adjusted net income $23.2M.
- Adjusted EBITDA $30.1M vs $13.4M YoY; operating income $20.7M vs $6.2M.
- FY2025 revenue guidance raised to $500-525M (4-9% YoY); Adj. net income guided $21.5-38.4M.
- Cash $64.4M, no debt; cash down from $136.2M due to operations.

## SEC filing metadata
- accession: 0001193125-25-269654
- form_type: 8-K
- ticker: ORGO
- cik: 0001661181
- company_name: Organogenesis Holdings Inc.
- filed_at: 2025-11-06T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1661181/000119312525269654/0001193125-25-269654-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1661181/000119312525269654/orgo-20251106.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-25-269654
- JSON: https://secwatch.observer/filing/0001193125-25-269654.json
- Plain text: https://secwatch.observer/filing/0001193125-25-269654.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.